Active Ingredient History
Quercetin is a unique bioflavonoid that has been extensively studied by researchers over the past 30 years. Quercetin, the most abundant of the flavonoids (the name comes from the Latin –quercetum, meaning oak forest, quercus oak) consists of 3 rings and 5 hydroxyl groups. Quercetin is a member of the class of flavonoids called flavonoles and forms the backbone for many other flavonoids including the citrus flavonoids like rutin, hesperidins, Naringenin and tangeritin. It is widely distributed in the plant kingdom in rinds and barks. The best described property of Quercetin is its ability to act as antioxidant. Quercetin seems to be the most powerful flavonoids for protecting the body against reactive oxygen species, produced during the normal oxygen metabolism or are induced by exogenous damage [9, 10]. One of the most important mechanisms and the sequence of events by which free radicals interfere with the cellular functions seem to be the lipid peroxidation leading eventually the cell death. To protect this cellular death to happen from reactive oxygen species, living organisms have developed antioxidant line of defense systems [11]. These include enzymatic and non-enzymatic antioxidants that keep in check ROS/RNS level and repair oxidative cellular damage. The major enzymes, constituting the first line of defence, directly involved in the neutralization of ROS/RNS are: superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPx) The second line of defence is represented by radical scavenging antioxidants such as vitamin C, vitamin A and plant phytochemicals including quercetin that inhibit the oxidation chain initiation and prevent chain propagation. This may also include the termination of a chain by the reaction of two radicals. The repair and de novo enzymes act as the third line of defence by repairing damage and reconstituting membranes. These include lipases, proteases, DNA repair enzymes and transferases. Quercetin is a specific quinone reductase 2 (QR2) inhibitor, an enzyme (along with the human QR1 homolog) which catalyzes metabolism of toxic quinolines. Inhibition of QR2 in plasmodium may potentially cause lethal oxidative stress. The inhibition of antioxidant activity in plasmodium may contribute to killing the malaria causing parasites. NCATS
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Aging (Phase 2)
Altitude Sickness (Phase 3)
Alzheimer Disease (Phase 2)
Asthma (Phase 2)
Autism Spectrum Disorder (Phase 2)
Carcinoma, Squamous Cell (Phase 2)
Cognitive Dysfunction (Phase 2)
Coronary Artery Disease (Phase 3)
COVID-19 (Phase 4)
Diabetes Mellitus, Type 2 (Phase 2)
Drug-Related Side Effects and Adverse Reactions (Phase 1/Phase 2)
Fanconi Anemia (Phase 2)
Flushing (Phase 4)
Frailty (Phase 2)
Gastroesophageal Reflux (Phase 1)
Healthy Volunteers (Phase 2)
Hepatitis C, Chronic (Phase 1)
Hyperuricemia (Phase 4)
Idiopathic Pulmonary Fibrosis (Phase 1)
Lichen Planus (Phase 1)
Lymphoma, Follicular (Phase 2)
Macular Degeneration (Phase 2)
Menopause (Phase 4)
Neoplasms (Phase 2)
Pain (Early Phase 1)
Peripheral Nerve Injuries (Early Phase 1)
Phytotherapy (Phase 1)
Prostatic Neoplasms (Phase 2)
Psoriasis (Phase 1)
Pulmonary Disease, Chronic Obstructive (Phase 1/Phase 2)
Renal Insufficiency, Chronic (Phase 2)
Severe Acute Respiratory Syndrome (Phase 1)
Stroke (Early Phase 1)
Thromboembolism (Phase 3)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue